ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 226 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $192,691,423 | -22.7% | 5,405,089 | 0.0% | 4.07% | -14.3% |
| Q2 2023 | $249,336,756 | +45.6% | 5,405,089 | +26.6% | 4.75% | +33.1% |
| Q1 2023 | $171,266,940 | -6.8% | 4,270,996 | +7.7% | 3.57% | -5.0% |
| Q4 2022 | $183,787,172 | +88.1% | 3,966,915 | +68.1% | 3.75% | +66.5% |
| Q3 2022 | $97,727,000 | +19.3% | 2,359,996 | +71.9% | 2.25% | +6.4% |
| Q2 2022 | $81,930,000 | -17.8% | 1,373,284 | 0.0% | 2.12% | +2.6% |
| Q1 2022 | $99,728,000 | -13.6% | 1,373,284 | 0.0% | 2.06% | +22.4% |
| Q4 2021 | $115,479,000 | – | 1,373,284 | – | 1.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |